TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). (Q43766458)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). |
scientific article |
Statements
1 reference
TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). (English)
1 reference
Meier C
1 reference
Staub JJ
1 reference
Roth CB
1 reference
Guglielmetti M
1 reference
Kunz M
1 reference
Miserez AR
1 reference
Drewe J
1 reference
Huber P
1 reference
Herzog R
1 reference
Müller B
1 reference
1 October 2001
1 reference
1 reference
86
1 reference
10
1 reference
4860-4866
1 reference
Identifiers
1 reference
1 reference